No Data
No Data
Express News | Noon announcement: "Mai Mi Zhuan 2," and Xin Tian convertible bonds will soon stop converting shares.
Guiyang Xintian Pharmaceutical (002873.SZ) plans to distribute a mid-term profit of 0.4 yuan per share.
Guiyang Xintian Pharmaceutical (002873.SZ) announced that the profit distribution plan for the mid-term of 2024 is: based on future actual...
Xintian Pharmaceutical Amends Business License
Xintian Pharmaceutical: Report for the third quarter of 2024
Guiyang Xintian Pharmaceutical (002873.SZ) released its performance for the first three quarters, with a net income of 60.9998 million yuan, a year-on-year decrease of 30.45%.
Guiyang Xintian Pharmaceutical (002873.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
The concept of innovative drugs in A-shares is active, with Guiyang Xintian Pharmaceutical and Jiangsu Sihuan Bioengineering hitting the daily limit.
Gelonghui October 24th | Guiyang Xintian Pharmaceutical, Jiangsu Sihuan Bioengineering limit up, Hainan Poly Pharm, Beijing Beilu Pharmaceutical, Huosen Biology and other leading gains.
No Data